Alkermes Catches A 'Sell' Downgrade On Depression Therapy, M&A Prospects

Stock drop of 8% today is just the beginning. Article below shows wall street realizing that not only is pipeline not going to perform but that the failure of 5461 and the preliminary data on your olanzapine molecule also spells there would likely be no suites for any reason for another bigger pharma company to acquire. So, all you hanging on in the hopes that a bigger company would come in and pay a stock price premium for ya all may want to reconsider and jump ship while you can. Below is just one of the many negative analyst articles that hit the street yesterday and today.

https://finance.yahoo.com/news/alkermes-catches-sell-downgrade-depression-142913766.html

 

Is the name of the source that published this article really “Benzinga”?

Sounds like the newest flavor of Monster Energy Drink.

“Now available in tangy “Benzinga” flavor”

 

Merry Christmas and Happy Holidays! It’s a great time to be at ALKS. Rejoice!

 

IF it drops any more, I may owe them money on my useless and worthless stock options.

 

Alks will be sold off by early Spring. Big pharma will come in, sell off Vivitrol and Aristada and use what ever molecules they can for other R&d. The bad news is all of us will be gone and the stock is worth nothing.

What do you think they brought in JR and JW? They know how big pharma works and will help get the bidding up.

 

Cashed out in the $ixties. Thank you ALKS!

 

WTF?! Did you even read the article. With no pipeline and only two products, both of which they state are facing strong headwinds and will stagnate with slower growth, they believe there is little chance that anyone would make a serious play for the company. Do your job and hit your numbers and you will be fine.

 

Um... Ah.... The analyst that downgraded us was Terrance Flynn from Goldman Sachs who is one of the most respected analysts on any investment banking team. Don't be a twit and read the entire article any maybe, just maybe learn how business works. Fat, drunk and stupid is no way to go through life, son.

 

I know who Terrence Flynn is.

He’s a respected stock analyst and company spokesman for Monster Energy Drink, now available in tangy “Benzinga” flavor.

 

A simple, "I'm an idiot. Thanks for calling me out" would have sufficed.

 

Another stock downgrade by the analysts. What is going on here?!!?

https://finance.yahoo.com/news/alkermes-catches-sell-downgrade-depression-142913766.html

 

The curtain has finally been pulled back and all the smoke and mirrors are gone. The analysts and industry see what Alks really is and what the future looks like and have spoken. The pipeline is clogged with me too compounds, crappy science and poorly executed studies as the FDA noted in the Advisory Board Meeting in November. Good luck to us all.

 

Stocks headed to the moon. We are #1

 

I am so proud to work at this outdated, failing company with shitty leaders. It is the best place ever and I love all of the people that have worked there more than 10 years and have no idea what a real pharma company does. I love you ALKS!

 

What analysts are saying about 3831 is the most concerning thing to me. No change in metabolic profile compared to olanzapine and little effect on weight gain. This will be impossible to sell to physicians or health care plans. It looks like it is just aristada and vivitrol for the forseeable future. That won't support all the people we are adding. Scared.

 

Is 3831 generic zyprexa with samadorphan added. Like samadorphan that was added to bupenorphine to make 5461? Was it really that we just added samadorphan to both zyprexa and buprenorphine? What will we add samadorphan to next? Viagra? Cialus? WTF? We just going to keep adding it to every generic compound we feel like to see if it does anything?

 

True innovation at its finest.

Have a problem? Put a little samidorphin on it, that should do it.